The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy
Tumor is the most serious threat to human beings. Although war against cancer has been launched over forty years, cancer treatment is still far away from being satisfactory. Immunotherapy, especially checkpoint blockade immunotherapy, is a rising star that shows a promising future. To fulfill the re...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2018/3673295 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849412211140722688 |
|---|---|
| author | Huan Zhao Yuanqi Li Dan Wei Hongrong Luo |
| author_facet | Huan Zhao Yuanqi Li Dan Wei Hongrong Luo |
| author_sort | Huan Zhao |
| collection | DOAJ |
| description | Tumor is the most serious threat to human beings. Although war against cancer has been launched over forty years, cancer treatment is still far away from being satisfactory. Immunotherapy, especially checkpoint blockade immunotherapy, is a rising star that shows a promising future. To fulfill the requirement of depleting primary tumor and inhibiting tumor metastasis and recurrence, many researchers combined checkpoint blockade immunotherapy with other treatment strategies to extend the treatment outcome. Photodynamic therapy could induce immunogenic cell death, and checkpoint blockade could further accelerate the immunity; therefore, combining these two strategies publishes many papers. Additionally, photothermal therapy and immunotherapy were also utilized for combining with checkpoint blockade, which were also reviewed in this paper. Furthermore, antibodies, siRNA, and small molecule inhibitors are developed to block the checkpoint; therefore, we categorized the papers into three sections, combination nanoparticles with checkpoint blockade antibody, combination nanoparticles with checkpoint blockade siRNA, and combination nanoparticles with small molecule checkpoint inhibitors, and related researches were summarized. In conclusion, the combination nanoparticle with checkpoint blockade cancer immunity is a promising direction that may fulfill the requirement of cancer treatment. |
| format | Article |
| id | doaj-art-6352ff1273874bd7b3541d5149df899c |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-6352ff1273874bd7b3541d5149df899c2025-08-20T03:34:30ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/36732953673295The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer ImmunotherapyHuan Zhao0Yuanqi Li1Dan Wei2Hongrong Luo3National Engineering Research Center for Biomaterial, Sichuan University, Sichuan, Chengdu 610064, ChinaNational Engineering Research Center for Biomaterial, Sichuan University, Sichuan, Chengdu 610064, ChinaNational Engineering Research Center for Biomaterial, Sichuan University, Sichuan, Chengdu 610064, ChinaNational Engineering Research Center for Biomaterial, Sichuan University, Sichuan, Chengdu 610064, ChinaTumor is the most serious threat to human beings. Although war against cancer has been launched over forty years, cancer treatment is still far away from being satisfactory. Immunotherapy, especially checkpoint blockade immunotherapy, is a rising star that shows a promising future. To fulfill the requirement of depleting primary tumor and inhibiting tumor metastasis and recurrence, many researchers combined checkpoint blockade immunotherapy with other treatment strategies to extend the treatment outcome. Photodynamic therapy could induce immunogenic cell death, and checkpoint blockade could further accelerate the immunity; therefore, combining these two strategies publishes many papers. Additionally, photothermal therapy and immunotherapy were also utilized for combining with checkpoint blockade, which were also reviewed in this paper. Furthermore, antibodies, siRNA, and small molecule inhibitors are developed to block the checkpoint; therefore, we categorized the papers into three sections, combination nanoparticles with checkpoint blockade antibody, combination nanoparticles with checkpoint blockade siRNA, and combination nanoparticles with small molecule checkpoint inhibitors, and related researches were summarized. In conclusion, the combination nanoparticle with checkpoint blockade cancer immunity is a promising direction that may fulfill the requirement of cancer treatment.http://dx.doi.org/10.1155/2018/3673295 |
| spellingShingle | Huan Zhao Yuanqi Li Dan Wei Hongrong Luo The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy Journal of Immunology Research |
| title | The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy |
| title_full | The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy |
| title_fullStr | The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy |
| title_full_unstemmed | The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy |
| title_short | The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy |
| title_sort | application of nanoparticle based drug delivery systems in checkpoint blockade cancer immunotherapy |
| url | http://dx.doi.org/10.1155/2018/3673295 |
| work_keys_str_mv | AT huanzhao theapplicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT yuanqili theapplicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT danwei theapplicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT hongrongluo theapplicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT huanzhao applicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT yuanqili applicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT danwei applicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy AT hongrongluo applicationofnanoparticlebaseddrugdeliverysystemsincheckpointblockadecancerimmunotherapy |